Pommergaard Hans-Christian, Rostved Andreas A, Adam René, Thygesen Lau C, Salizzoni Mauro, Gómez Bravo Miguel A, Cherqui Daniel, Filipponi Franco, Boudjema Karim, Mazzaferro Vincenzo, Soubrane Olivier, García-Valdecasas Juan C, Prous Joan F, Pinna Antonio D, O'Grady John, Karam Vincent, Duvoux Christophe, Rasmussen Allan
Department of Surgical Gastroenterology and Transplantation, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Department of Surgical Gastroenterology and Transplantation, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
HPB (Oxford). 2018 Aug;20(8):768-775. doi: 10.1016/j.hpb.2018.03.002. Epub 2018 Apr 3.
Studies suggest that vascular invasion may be a superior prognostic marker compared with traditional selection criteria, e.g. Milan criteria. This study aimed to investigate the prognostic value of micro and macrovascular invasion in a large database material.
Patients liver transplanted for HCC and cirrhosis registered in the European Liver Transplant Registry (ELTR) database were included. The association between the Milan criteria, Up-to-seven criteria and vascular invasion with overall survival and HCC specific survival was investigated with univariate and multivariate Cox regression analyses.
Of 23,124 patients transplanted for HCC, 9324 had cirrhosis and data on explant pathology. Patients without microvascular invasion, regardless of number and size of HCC nodules, had a five-year overall survival of 73.2%, which was comparable with patients inside both Milan and Up-to-seven criteria. Patients without macrovascular invasion had an only marginally reduced survival of 70.7% after five years. Patients outside both Milan and Up-to-seven criteria without micro or macrovascular invasion still had a five-year overall survival of 65.8%.
Vascular invasion as a prognostic indicator remains superior to criteria based on size and number of nodules. With continuously improving imaging studies, microvascular invasion may be used for selecting patients for transplantation in the future.
研究表明,与传统选择标准(如米兰标准)相比,血管侵犯可能是一个更好的预后标志物。本研究旨在调查在一个大型数据库资料中微血管和大血管侵犯的预后价值。
纳入欧洲肝脏移植登记处(ELTR)数据库中因肝癌和肝硬化接受肝移植的患者。采用单因素和多因素Cox回归分析,研究米兰标准、七项标准和血管侵犯与总生存期和肝癌特异性生存期之间的关联。
在23124例因肝癌接受移植的患者中,9324例患有肝硬化且有移植肝病理数据。无微血管侵犯的患者,无论肝癌结节的数量和大小如何,其五年总生存率为73.2%,这与符合米兰标准和七项标准的患者相当。无大血管侵犯的患者五年后的生存率仅略有下降,为70.7%。不符合米兰标准和七项标准且无微血管或大血管侵犯的患者五年总生存率仍为65.8%。
血管侵犯作为一种预后指标仍然优于基于结节大小和数量的标准。随着影像学研究的不断改进,微血管侵犯未来可能用于选择移植患者。